Resumption Dates for WHO FCTC COP10 and MOP3 Announced

Events by 2FIRSTS.ai
Nov.29.2023
Resumption Dates for WHO FCTC COP10 and MOP3 Announced
The World Health Organization has announced the resumption dates for the COP10 and MOP3 meetings in 2024.

According to an announcement from the World Health Organization on November 27th, the resumption dates for the Tenth Session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control (COP10) and the Third Session of the Meeting of the Parties to the Protocol to Eliminate Illicit Trade in Tobacco Products (MOP3) have been scheduled for February 5th, 2024.

 

In the announcement, it was mentioned that after consultation with the host country Panama, the resumption dates for COP10 and MOP3 have been confirmed. The specific schedule is as follows:

 

The COP10 meeting of the WHO Framework Convention on Tobacco Control will resume from Monday, February 5, 2024 to Saturday, February 10, 2024. The MOP3 meeting of the Protocol to Eliminate Illicit Trade in Tobacco Products will resume from Monday, February 12, 2024 to Thursday, February 15, 2024. The World Health Organization expressed its anticipation for the participation of all contracting parties in the upcoming supervisory meetings of the WHO Framework Convention on Tobacco Control and the Protocol to Eliminate Illicit Trade in Tobacco Products. The Secretariat of the conventions, in collaboration with the host country, remains committed to the life-saving work of tobacco control.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
At the InterTabac opening press conference, German tobacco industry leaders criticized the EU’s proposed tax reform, warning that steep hikes could devastate the nicotine pouch sector, reduce excise revenue, and fuel illicit trade. They called on German policymakers to oppose the changes at the European level.
Sep.19
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Market research firm LP Information has released a global e-cigarette market report forecasting that the e-cigarette device market—including both disposable and reusable devices—will reach US$34.29 billion by 2031, with a 9.4% CAGR from 2025 to 2031.
Oct.16
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York AG Seeks to Shut Down Vape Shops, Ban Owners from Industry
New York Attorney General Letitia James has filed a petition seeking to permanently shut down two smoke shops and ban their owners from the vape industry for repeatedly selling illegal flavored vapes to minors and operating without valid licenses. The nearly 50-page complaint names Eysa Sharhan and Ahmed Mozeb and their stores — Pop-In Smoke & Vape LLC, Pufftopia LLC, and Royalty Tobacco LLC — accusing them of a “persistent pattern of illegal activity.”
Oct.24 by 2FIRSTS.ai
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian Duma considers comprehensive regulations to address widespread e-cigarette use among youth, including potential sales bans and flavor restrictions.
Oct.20 by 2FIRSTS.ai
新闻标题:Cigar Sense启动新研究:雪茄消费者期待与实际体验的关联
新闻标题:Cigar Sense启动新研究:雪茄消费者期待与实际体验的关联
Carson City, Nevada, Sept 19, 2025—A new study by Cigar Sense Inc. explores the impact of consumer expectations on cigar experiences.
Sep.23 by 2FIRSTS.ai
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
New materials related to Philip Morris Products' MRTP renewal application have been submitted to the FDA for review.
Sep.26 by 2FIRSTS.ai